How Does a Drug Get Its Name?

Have you ever wondered where FOP drug names like Sohonos™, Pasatru™ or Atebrioz™ come from?

Before a new medicine reaches the pharmacy, it picks up two names. One is the generic name, like atorvastatin, which describes the medicine itself. The other is the brand name, like Lipitor, which a company chooses and markets.

Each name goes through its own approval process, and both take more thought than you might expect.

Who picks the generic name?

In the U.S., the United States Adopted Names (USAN) Council assigns generic names. The council is sponsored by the American Medical Association, the U.S. Pharmacopeia, and the American Pharmacists Association, and it works with a U.S. Food & Drug Administration (FDA) liaison. The FDA technically has the legal authority to name drugs, but in practice it defers to USAN.

Companies usually apply for a generic name during early clinical trials, around Phase 1 or 2, once they're fairly confident a compound is worth pursuing. The company can suggest names, and there's often some back-and-forth before everyone agrees. USAN also coordinates with the World Health Organization, so the same generic name can be used worldwide.

Names that tell a story

Generic names aren't random. They're built from standardized "stems" that signal what kind of drug it is, so doctors and pharmacists can tell at a glance how it works. A few common ones:

  • -mab marks a monoclonal antibody
  • -tinib marks a tyrosine kinase inhibitor
  • -pril marks an ACE inhibitor, used for blood pressure
  • -olol marks a beta blocker

You can see this in drugs studied for FOP. Garetosmab ends in -mab, which tells you it's a monoclonal antibody. Zilurgisertib ends in -sertib, which marks a serine/threonine kinase inhibitor.

Biologics, like antibodies, get one more twist. Since 2017, FDA guidance has them carry a four-letter suffix with no meaning, so products from different manufacturers can be told apart. That's why you may see garetosmab written as garetosmab-grts.

The brand name: from thousands to one

Brand names follow a different path. Companies usually work with specialized naming agencies that come up with hundreds or even thousands of candidates. That list is then narrowed through trademark searches, checks for unfortunate meanings in other languages, marketing appeal, and the company's own safety testing.

The name has to work worldwide, too. Because the drug will also need approval from regulators like the European Medicines Agency (EMA), companies look for a name that holds up across markets.

What the FDA looks for

Once a company settles on a name, it goes to the FDA. The agency's main question is whether the name could be mistaken for a drug that's already on the market. Look-alike and sound-alike names, like Celebrex, Celexa, and Cerebyx, are a real source of medication errors.

To check, the FDA runs proposed names through a computer system that scores how similar they are to existing ones. Staff also run simulations where clinicians read handwritten prescriptions, listen to verbal orders, and enter electronic orders to see whether the name gets misread.

The FDA also makes sure a name doesn't overpromise. It can't imply the drug is a cure, overstate how well it works, or suggest it's better than other treatments. It also can't include medical abbreviations, hint at a dosing schedule, or borrow a generic-name stem.

Always have a backup

Companies submit their proposed name along with a backup, and for good reason: roughly one in three proposed names is rejected. Even an accepted name gets a second look closer to approval, since new drug names may have entered the market in the meantime.

FOP brand names went through this same careful process:

  • Sohonos (so-HO-nos)
  • Pasatru (PA-sah-troo)
  • Atebrioz (ah-TEB-ree-oz)

A quick explanation

A generic name tells you what kind of medicine you're looking at. A brand name has survived a long list of checks to make sure it's safe, clear, and honest. So the next time you see both on a label, you'll know each one had to earn its place.

Make a Difference

Donate Connect Fundraise
Already a Member? Sign In

Sign Up for FOP Connection, Our Monthly eNewsletter

X